Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology

J Am Coll Cardiol. 2015 Dec 1;66(21):2362-2371. doi: 10.1016/j.jacc.2015.09.035. Epub 2015 Nov 2.
No abstract available

Keywords: ACC/AHA Scientific Statements; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy; cardiovascular abnormalities; cardiovascular magnetic resonance; hypertrophic cardiomyopathy; myocarditis; sudden death.

MeSH terms

  • Adolescent
  • Adult
  • Advisory Committees*
  • American Heart Association*
  • Arrhythmogenic Right Ventricular Dysplasia / complications
  • Arrhythmogenic Right Ventricular Dysplasia / diagnosis*
  • Arrhythmogenic Right Ventricular Dysplasia / epidemiology
  • Athletes*
  • Cardiology / standards*
  • Cardiomyopathies / complications
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / epidemiology
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / diagnosis*
  • Cardiomyopathy, Hypertrophic / epidemiology
  • Cardiovascular Abnormalities / complications
  • Cardiovascular Abnormalities / diagnosis
  • Cardiovascular Abnormalities / epidemiology
  • Child
  • Female
  • Humans
  • Male
  • Myocarditis / complications
  • Myocarditis / diagnosis*
  • Myocarditis / epidemiology
  • Practice Guidelines as Topic / standards
  • United States / epidemiology
  • Young Adult